ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)
Public ClinicalTrials.gov record NCT05134662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Tolerability, Pharmacodynamics and Pharmacokinetics of ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus
Study identification
- NCT ID
- NCT05134662
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Altimmune, Inc.
- Industry
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Interventions
- ALT-801 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2022
- Primary completion
- Feb 2, 2023
- Completion
- Mar 8, 2023
- Last update posted
- Jun 23, 2025
2022 – 2023
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altimmune CTM | Fort Myers | Florida | 33900 | — |
| Altimmune CTM | Sarasota | Florida | 34230 | — |
| Altimmune CTM | River Forest | Illinois | 60305 | — |
| Altimmune CTM | Kansas City | Missouri | 64101 | — |
| Altimmune CTM | Knoxville | Tennessee | 37922 | — |
| Altimmune CTM | San Antonio | Texas | 78201 | — |
| Altimmune CTM | Tomball | Texas | 77375 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05134662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2025 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05134662 live on ClinicalTrials.gov.